Prof
Diabetes
University of Yaounde
Cameroon
These findings provide a variety drug development targets according to the genetic risk in the form of signal pathways that can reduce the progression of multiple metabolic phenotypes or the risk of their complications by personalization of medicine. These findings provide a variety drug development targets according to the genetic risk in the form of signal pathways that can reduce the progression of multiple metabolic phenotypes or the risk of their complications by personalization of medicine.
Diabetes,Medicine,Healthcare,Public Health